{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T01:46:01Z","timestamp":1776735961273,"version":"3.51.2"},"reference-count":44,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"unspecified","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2024,11,14]]},"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The Assessment of SpondyloArthritis international Society Health Index (ASAS HI) is a novel questionnaire of global functioning for patients with axial spondyloarthritis (SpA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The objective was to assess the construct validity, discriminatory ability and responsiveness of ASAS HI in relation to patient-reported outcome measures (PROMs), MRI and radiography.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Data from two longitudinal studies with tumour necrosis factor inhibitor (TNFi) initiation (novel MRI And biomarkers in Golimumab-treated patients with axial spondyloarthritis (MANGO): n=45) respectively tapering (Dose adjustment of Biological treatment in patients with SpA (DOBIS): n=106) were used. Analyses included a wide panel of PROMs, MRI and radiography scores of the spine and sacroiliac joints (SIJs).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In the MANGO study, 30 (68%) patients were clinical responders at week 16. In the DOBIS study, 105 (99%) patients flared after mean (SD; min\u2013max) 31 (17; 2.7\u201381) weeks. After initiation of TNF inhibitor in MANGO, ASAS HI significantly decreased from baseline to week 4, 16 and 52. In DOBIS, ASAS significantly increased from baseline to the flare visit and significantly decreased from the flare visit to week 96. In multivariate regression models, ASAS HI was independently associated with Spondyloarthritis Research Consortium of Canada MRI SIJ Inflammation score, Canada-Denmark MRI Spine Inflammation score, EuroQol, Ankylosing Spondylitis Disease Activity Index, Bath Ankylosing Spondylitis Disease Activity Index and Patient Global. Patients stratified according to ASAS HI health status groups (good, moderate, poor) at baseline and change categories (absolute and percentage change) from baseline to week 16\/flare showed good discriminatory ability for almost all outcome variables (p\u22640.001). ASAS HI had a large responsiveness in MANGO (standardised response mean (SRM)=\u22121.3, effect size (ES)=\u22121.7) and moderate responsiveness in DOBIS (SRM=0.7, ES=0.6).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>ASAS HI showed good construct validity, discriminatory ability and responsiveness.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>ClinicalTrials.gov: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT02011386\">NCT02011386<\/jats:ext-link>.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2024-004948","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T23:40:17Z","timestamp":1734738017000},"page":"e004948","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Construct validity and responsiveness of ASAS Health Index assessed in two longitudinal studies of tumour necrosis factor alpha inhibitor initiation and dose reduction in patients with axial spondyloarthritis"],"prefix":"10.1136","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct02011386","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2168-7802","authenticated-orcid":false,"given":"Mate","family":"Lorincz","sequence":"first","affiliation":[{"name":"Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3690-467X","authenticated-orcid":false,"given":"Mikkel","family":"\u00d8stergaard","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Wetterslev","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge Juul","family":"S\u00f8rensen","sequence":"additional","affiliation":[{"name":"Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole Rintek","family":"Madsen","sequence":"additional","affiliation":[{"name":"Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5063-9932","authenticated-orcid":false,"given":"Sara Nysom","family":"Christiansen","sequence":"additional","affiliation":[{"name":"Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4229-6818","authenticated-orcid":false,"given":"Merete Lund","family":"Hetland","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark"},{"name":"Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark"},{"name":"The DANBIO Registry, Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mads","family":"Bakkegaard","sequence":"additional","affiliation":[{"name":"Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette","family":"Klarlund","sequence":"additional","affiliation":[{"name":"Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Duer","sequence":"additional","affiliation":[{"name":"Department of Radiology, Rigshospitalet Glostrup, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8774-6563","authenticated-orcid":false,"given":"Mikael","family":"Boesen","sequence":"additional","affiliation":[{"name":"Department of Radiology, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasper Kj\u00e6rulf","family":"Gosvig","sequence":"additional","affiliation":[{"name":"Department of Radiology, Herlev and Gentofte Hospital, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6500-9263","authenticated-orcid":false,"given":"Susanne Juhl","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"key":"2025090313553404000_10.4.e004948.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31591-4"},{"key":"2025090313553404000_10.4.e004948.2","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003468","article-title":"Work productivity in patients with axial spondyloarthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review and meta-analysis","volume":"9","author":"Rudwaleit","year":"2023","journal-title":"RMD Open"},{"key":"2025090313553404000_10.4.e004948.3","doi-asserted-by":"crossref","DOI":"10.1186\/s12955-022-02026-5","article-title":"The validity and reliability of quality of life questionnaires in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and meta-analysis","volume":"20","author":"He","year":"2022","journal-title":"Health Qual Life Outcomes"},{"key":"2025090313553404000_10.4.e004948.4","first-page":"951","article-title":"Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis","volume":"26","author":"van der Heijde","year":"1999","journal-title":"J Rheumatol"},{"key":"2025090313553404000_10.4.e004948.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2021.07.021"},{"key":"2025090313553404000_10.4.e004948.6","unstructured":"The International Classification of Functioning Disability and Health. Geneva: World HealthOrganization . 2001."},{"key":"2025090313553404000_10.4.e004948.7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212076"},{"key":"2025090313553404000_10.4.e004948.8","first-page":"105","article-title":"The ASAS Health Index (ASAS HI) - a new tool to assess the health status of patients with spondyloarthritis","volume":"32","author":"Kiltz","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"2025090313553404000_10.4.e004948.9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq315"},{"key":"2025090313553404000_10.4.e004948.10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203967"},{"key":"2025090313553404000_10.4.e004948.11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3346\/jkms.2014.29.3.334","article-title":"The reliability and validity of a Korean translation of the ASAS Health Index and Environmental Factors in Korean patients with axial spondyloarthritis","volume":"29","author":"Choi","year":"2014","journal-title":"J Korean Med Sci"},{"key":"2025090313553404000_10.4.e004948.12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235678","article-title":"Gender difference in ASAS HI among patients with ankylosing spondylitis","volume":"15","author":"Chen","year":"2020","journal-title":"PLoS ONE"},{"key":"2025090313553404000_10.4.e004948.13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-071944","article-title":"Association of anxiety, depression and resilience with overall health and functioning in axial spondyloarthritis (axSpA): a cross-sectional study","volume":"13","author":"Chung","year":"2023","journal-title":"BMJ Open"},{"key":"2025090313553404000_10.4.e004948.14","doi-asserted-by":"crossref","DOI":"10.1186\/s12955-016-0463-1","article-title":"Clinimetric properties of the ASAS health index in a cohort of Italian patients with axial spondyloarthritis","volume":"14","author":"Di Carlo","year":"2016","journal-title":"Health Qual Life Outcomes"},{"key":"2025090313553404000_10.4.e004948.15","doi-asserted-by":"crossref","unstructured":"Kiefer D , Braun J , Kiltz U , et al . n.d. Global Functioning in Axial Spondyloarthritis is Stronger Associated With Disease Activity and Function Than With Mobility and Radiographic Damage. Arthritis Care & Research. doi:10.1002\/acr.25204","DOI":"10.1002\/acr.25204"},{"key":"2025090313553404000_10.4.e004948.16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10067-021-05957-4","article-title":"Real-world effectiveness and rheumatologist satisfaction with secukinumab in the treatment of patients with axial spondyloarthritis","volume":"41","author":"Kiltz","year":"2022","journal-title":"Clin Rheumatol"},{"key":"2025090313553404000_10.4.e004948.17","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s40744-023-00550-4","article-title":"Effect of Upadacitinib on Quality of Life and Work Productivity in Active Non-radiographic Axial Spondyloarthritis: Results From Randomized Phase 3 Trial SELECT-AXIS 2","volume":"10","author":"Kiltz","year":"2023","journal-title":"Rheumatol Ther"},{"key":"2025090313553404000_10.4.e004948.18","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.220244"},{"key":"2025090313553404000_10.4.e004948.19","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200093"},{"key":"2025090313553404000_10.4.e004948.20","doi-asserted-by":"crossref","first-page":"152006","DOI":"10.1016\/j.semarthrit.2022.152006","article-title":"Effects of patient and disease characteristics on global functioning in patients with axial spondyloarthritis in routine care","volume":"55","author":"Kiltz","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"2025090313553404000_10.4.e004948.21","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/1756-185X.13640","article-title":"Validity and reliability of the Assessment of Spondyloarthritis International Society Health Index in English-speaking patients with axial spondyloarthritis in Singapore","volume":"22","author":"Kwan","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"2025090313553404000_10.4.e004948.22","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8040467","article-title":"Predictors of Assessment of Spondyloarthritis International Society (ASAS) Health Index in Axial Spondyloarthritis and Comparison of ASAS Health Index between Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Data from the Catholic Axial Spondyloarthritis COhort (CASCO)","volume":"8","author":"Min","year":"2019","journal-title":"J Clin Med"},{"key":"2025090313553404000_10.4.e004948.23","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219585"},{"key":"2025090313553404000_10.4.e004948.24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s40744-023-00536-2","article-title":"Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis","volume":"10","author":"Navarro-Comp\u00e1n","year":"2023","journal-title":"Rheumatol Ther"},{"key":"2025090313553404000_10.4.e004948.25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.55563\/clinexprheumatol\/zr61xv","article-title":"ASAS Health Index in patients with spondyloarthritis and its association with disease activity and disease burden including fibromyalgia","volume":"39 Suppl 130","author":"Puche Larrubia","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"2025090313553404000_10.4.e004948.26","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003587","article-title":"Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort","volume":"9","author":"Redeker","year":"2023","journal-title":"RMD Open"},{"key":"2025090313553404000_10.4.e004948.27","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.220212"},{"key":"2025090313553404000_10.4.e004948.28","first-page":"26","article-title":"The European Portuguese version of the ASAS Health Index for Patients with Spondyloarthritis: Measurement properties","volume":"45","author":"Rodrigues-Manica","year":"2020","journal-title":"Acta Reumatol Port"},{"key":"2025090313553404000_10.4.e004948.29","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1093\/rheumatology\/keaa153","article-title":"Novel whole-body magnetic resonance imaging response and remission criteria document diminished inflammation during golimumab treatment in axial spondyloarthritis","volume":"59","author":"Krabbe","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2025090313553404000_10.4.e004948.30","first-page":"2398","article-title":"Tapering of TNF inhibitors in axial spondyloarthritis in routine care - 2-year clinical and MRI outcomes and predictors of successful tapering","volume":"61","author":"Wetterslev","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2025090313553404000_10.4.e004948.31","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.110767"},{"key":"2025090313553404000_10.4.e004948.32","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.108233"},{"key":"2025090313553404000_10.4.e004948.33","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2022-222747"},{"key":"2025090313553404000_10.4.e004948.34","doi-asserted-by":"publisher","DOI":"10.1002\/art.21445"},{"key":"2025090313553404000_10.4.e004948.35","doi-asserted-by":"publisher","DOI":"10.1002\/art.21337"},{"key":"2025090313553404000_10.4.e004948.36","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001057","article-title":"Canada-Denmark MRI scoring system of the spine in patients with axial spondyloarthritis: updated definitions, scoring rules and inter-reader reliability in a multiple reader setting","volume":"5","author":"Krabbe","year":"2019","journal-title":"RMD Open"},{"key":"2025090313553404000_10.4.e004948.37","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.020503"},{"key":"2025090313553404000_10.4.e004948.38","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270401"},{"key":"2025090313553404000_10.4.e004948.39","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140519"},{"key":"2025090313553404000_10.4.e004948.40","doi-asserted-by":"publisher","DOI":"10.1007\/S40258-017-0310-5"},{"key":"2025090313553404000_10.4.e004948.41","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(99)00206-1"},{"key":"2025090313553404000_10.4.e004948.42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.AD"},{"key":"2025090313553404000_10.4.e004948.43","first-page":"862","article-title":"Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment","volume":"34","author":"Lukas","year":"2007","journal-title":"J Rheumatol"},{"key":"2025090313553404000_10.4.e004948.44","doi-asserted-by":"publisher","DOI":"10.1002\/art.33453"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2024-004948","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:55:41Z","timestamp":1756932941000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2024-004948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,12,20]]},"published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1136\/rmdopen-2024-004948"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2024-004948","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}